Phase II clinical trial of suberoylanilide hydroxamic acid (SAHA) in patients (pts) with recurrent and/or metastatic head and neck cancer(SCCHN)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 5578-5578
Author(s):  
G. Blumenschein ◽  
C. Lu ◽  
M. Kies ◽  
B. Glisson ◽  
V. Papadimitrakopoulou ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Hydroxamic Acid ◽  
Phase Ii Clinical Trial ◽  
Suberoylanilide Hydroxamic Acid

scholarly journals OC-0486: Pravastatin reverses fibrosis in head and neck cancer patients: phase II clinical trial results

2018 ◽  
Vol 127 ◽  
pp. S250
Author(s):  
C. Bourgier ◽  
S. Rivera ◽  
M.C. Vozenin ◽  
P. Boisselier ◽  
D. Azria ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Clinical Trial ◽  
Clinical Trial Results
Sign in / Sign up

Export Citation Format

Share Document